NGL Fine-Chem Limited manufactures and sells pharmaceuticals and intermediates for usage in veterinary and human health in India, Europe, the Asia Pacific, the United States, and internationally. The company offers animal health pharmaceutical ingredients, such as homidium chloride, nitroxynil, clorsulon, parvaquone, buparvaquone, isometamidium chloride hydrochloride, toldimfos sodium, butaphosphan, imidocarb dipropionate, triclabendazole, rafoxanide, diminazene aceturate, s-methoprene, carprofen, diminazene diaceturate, ractopamine HCI, toltrazuril, decoquinate, amitraz, marbofloxacin, flunixin meglumine, praziquantel, fenbendazole, and xylazine hydrochloride. It also provides human health pharmaceutical ingredients, including nitazoxanide and atovaquone; and intermediates and specialty chemicals comprising 1,4,7-Trimethyl-1,4,7-Triazacylononane and N-ethyl glucamine. In addition, the company offers finished dosage forms, including diminazene aceturate granules and homidium chloride tablets. NGL Fine-Chem Limited was incorporated in 1981 and is based in Mumbai, India.
Low
1,271.00
High
3,602.00
Low
2,851.00
High
2,972.00
Company's profit divided by outstanding shares.
Ratio of share price to its earnings per share.
Total number of outstanding shares.
Gap between today's open and yesterday's close.
Average daily traded volume.
Highest price reached in the last 30 days.
Lowest price reached in the last 30 days.
Highest price reached in the last six months.
Lowest price reached in the last six months.
Highest price reached in the last year.
Lowest price reached in the last year.
How NGL Fine-Chem Limited stacks up against its Drug Manufacturers - General peers on price, valuation and the 52-week range. Tap any column header to sort.
| # | Name | Price | Chg % | P/E | EPS | Mkt Cap (Cr) | 1M % | 1Y % | 52W H/L |
|---|---|---|---|---|---|---|---|---|---|
| 1 | NGLFINE NGL Fine-Chem Limited | 2,900.00 | 0.33% | 31.27 | 92.73 | 1,792 | 1.19% | 102.51% | 3,602.00 / 1,271.00 |
| 2 | CORONA CORONA REMEDIES LIMITED | 2,021.10 | 3.45% | 62.11 | 32.54 | 12,412 | 5.96% | 42.93% | 2,292.40 / 1,336.60 |
| 3 | GLAXO GlaxoSmithKline Pharmaceuticals Limited | 2,760.00 | 0.34% | 43.77 | 63.05 | 46,965 | 6.56% | 0.93% | 3,120.70 / 2,088.10 |
| 4 | MARKSANS Marksans Pharma Limited | 323.05 | 0.23% | 28.32 | 11.41 | 14,719 | 1.00% | 90.70% | 350.95 / 155.00 |
| 5 | PFIZER Pfizer Limited | 3,857.00 | 0.47% | 24.00 | 160.70 | 17,654 | 20.77% | 25.83% | 5,578.50 / 3,792.10 |
| 6 | RUBICON RUBICON RESEARCH LIMITED | 1,628.00 | 0.53% | 93.28 | 17.45 | 26,949 | 8.34% | 159.03% | 1,899.00 / 570.75 |
| 7 | SAIPARENT SAI PARENTERALS LIMITED | 522.80 | 1.23% | 106.53 | 4.91 | 2,310 | 0.43% | 28.40% | 706.00 / 400.00 |
| 8 | SANOFI Sanofi India Limited | 3,040.00 | 0.56% | 21.62 | 140.59 | 6,995 | 7.23% | 40.91% | 4,898.00 / 3,001.10 |
| 9 | SANOFICONR SANOFI CONS HEALTHC IND L | 3,775.20 | 0.73% | 32.68 | 115.51 | 8,722 | 10.15% | 26.46% | 5,255.00 / 3,691.00 |
| 10 | SENORES SENORES PHARMACEUTICALS L | 1,335.30 | 3.64% | 49.39 | 27.03 | 6,150 | 11.45% | 93.48% | 1,599.00 / 684.60 |
| 11 | SMSPHARMA SMS Pharmaceuticals Limited | 470.95 | 1.19% | 42.23 | 11.15 | 4,411 | 32.98% | 98.04% | 494.45 / 245.21 |
| 12 | TTKHLTCARE TTK Healthcare Limited | 1,012.20 | 1.06% | 19.34 | 52.34 | 1,431 | 7.52% | 14.00% | 1,247.00 / 735.00 |